Publicaciones en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (221)

2024

  1. Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations

    European Heart Journal

  2. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure

  3. Effectiveness and safety of non-invasive ventilation in the management of cardiogenic shock

    Revista Portuguesa de Cardiologia, Vol. 43, Núm. 5, pp. 259-273

  4. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review

    Frontiers in Cardiovascular Medicine, Vol. 11

  5. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 60, Núm. 4, pp. 226-237

  6. Semi-quantitative pulmonary congestion score: prevalence and diuretic management implications after heart failure discharge

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 157-161

  7. The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study

    Nutrients, Vol. 16, Núm. 8

  8. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 851-858

2023

  1. Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  2. Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction

    Scientific Reports, Vol. 13, Núm. 1

  3. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

  4. Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients

    IJC Heart and Vasculature, Vol. 46

  5. Making STRONGer the transition phase: personalized GDMT through NT-proBNP monitoring

    European heart journal

  6. Personalizing anti-inflammatory therapy in heart failure: A new way

    European Journal of Heart Failure

2022

  1. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia

    Scientific Reports, Vol. 12, Núm. 1

  2. COLCHICINE ANTI-INFLAMMATORY THERAPY FOR NON-INTENSIVE CARE UNIT HOSPITALIZED COVID-19 PATIENTS: RESULTS FROM A PILOT OPEN-LABEL, RANDOMIZED CONTROLLED CLINICAL TRIAL

    Journal of Physiology and Pharmacology, Vol. 73, Núm. 3

  3. Circulating suPAR associates with severity and in-hospital progression of COVID-19

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

  4. Cost-effectiveness analysis of the SAPIEN 3 transcatheter aortic valve implant in patients with symptomatic severe aortic stenosis

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 325-333

  5. Critical warm ischemia time point for cardiac donation after circulatory death

    American Journal of Transplantation, Vol. 22, Núm. 5, pp. 1321-1328

  6. Environmental factors like air pollution: not to be forgotten in the 2021 ESC guidelines on heart failure. Response

    Revista Espanola de Cardiologia